A STUDY ON THE SAFETY AND EFFECTIVENESS OF TWICE-DAILY NELFINAVIR PLUS TWICE-DAILY INDINAVIR PLUS EFAVIRENZ IN HIV-POSITIVE PATIENTS WHO HAVE NEVER TAKEN NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIS) OR PROTEASE INHIBITORS: